Effects of Education on Stigma and Quality of Life in Individuals With Type 1 Diabetes
Effects of Anti-Stigma Psychoeducation Based on Roy Adaptation Model on Stigma and Quality of Life in Individuals With Type 1 Diabetes
1 other identifier
interventional
36
1 country
1
Brief Summary
This clinical trial aimed to examine the effects of anti-stigma psychoeducation based on the Roy Adaptation Model on stigma and quality of life in individuals with Type 1 Diabetes.The main questions it aims to answer are:
- 1.Does anti-stigma psychoeducation reduce stigma of individuals diagnosed with Type 1 Diabetes?
- 2.Does anti-stigma psychoeducation improve the quality of life of individuals diagnosed with Type 1 Diabetes?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 17, 2025
CompletedFirst Submitted
Initial submission to the registry
February 22, 2025
CompletedFirst Posted
Study publicly available on registry
February 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedApril 28, 2026
February 1, 2025
8 months
February 22, 2025
April 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Type 1 Diabetes Stigma Assessment Scale
Type 1 Diabetes Stigma Assessment Scale was developed by Browne et al. in 2017 to assess perceived and experienced stigma in adults diagnosed with type 1 diabetes. The scale consists of 19 items. The scale has 3 sub-dimensions; "treated differently", "Blame and judgment" and "Identity concerns" Each item is scored on a 5-point Likert scale. (1=strongly disagree, 2=disagree, 3=not sure, 4=agree, 5=strongly agree). Item scores are added to obtain the sub-dimensions and total score of the scale. A high score indicates an increase in perceived and felt stigma.
0 day, 7 weeks, 3 months
Secondary Outcomes (1)
Short Form-36
0 day, 7 weeks, 3 months
Study Arms (2)
Psychoeducation Group
EXPERIMENTALThe education is a group psychoeducation. Education methods such as role-play, discussion, demonstration, and narration will be applied. The education will be held once a week and will be completed in 7 weeks. Psychoeducation topics include adaptation to stigma in type 1 diabetes, coping, diabetes management, social life, self-esteem, roles in life and impact on life. Concepts such as stigma, blame, judgment, discrimination, shame and stereotyped thoughts will be included.
Control Group
NO INTERVENTIONNo intervention
Interventions
The education is a group psychoeducation. Education methods such as role-play, discussion, demonstration, and narration will be applied. The education will be held once a week and will be completed in 7 weeks. Psychoeducation topics include adaptation to stigma in type 1 diabetes, coping, diabetes management, social life, self-esteem, roles in life and impact on life. Concepts such as stigma, blame, judgment, discrimination, shame and stereotyped thoughts will be included.
Eligibility Criteria
You may qualify if:
- Diagnosed with Type 1 diabetes at least 6 months ago,
- Being between the ages of 18 and 75,
- Speaking and understanding Turkish,
You may not qualify if:
- Having hearing and vision impairment
- Being diagnosed with mental retardation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ege University
Izmir, Bornova, 35040, Turkey (Türkiye)
Related Publications (3)
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.
PMID: 1593914RESULTBrowne JL, Ventura AD, Mosely K, Speight J. Measuring Type 1 diabetes stigma: development and validation of the Type 1 Diabetes Stigma Assessment Scale (DSAS-1). Diabet Med. 2017 Dec;34(12):1773-1782. doi: 10.1111/dme.13507.
PMID: 28891210RESULTSatil EM, Arabaci LB. Turkish validity and reliability of Type-1 Diabetes Stigma Assessment Scale. North Clin Istanb. 2022 Dec 12;9(6):654-662. doi: 10.14744/nci.2021.36937. eCollection 2022.
PMID: 36685628RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Seyda Dülgerler, PhD
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- A diabetes education nurse will identify participants and assign numbers to the identified participants. A statistician will randomize the participant numbers. A different nurse will place the participants in the experimental and control groups according to the numbers. A statistician will evaluate the results of the education. Thus, the researcher will be blinded in both the participant selection and the outcome evaluation stages.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 22, 2025
First Posted
February 27, 2025
Study Start
July 1, 2024
Primary Completion
February 17, 2025
Study Completion
February 28, 2025
Last Updated
April 28, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
This experimental study is a thesis study. In order to preserve originality, I do not approve of sharing it.